000			a
999			_c15525 _d15525
003			OSt
005			20211120143135.0
008			211120b xxu||||| |||| 00| 0 eng d
040			_aAIKTC-KRRC _cAIKTC-KRRC
100			_914695 _a Fattepur, Santosh
245			_aCoordinated Androgen and Estrogen-receptor microRNA 26 Directive in Breast and Prostate Tumour
250			_aVol.55(3), Jul-Sep
260			_aBanagalore _bAssociation of Pharmaceutical Teachers of India (APTI) _c2021
300			_a738-747p.
520			_aMiR-26 is a miRNA tumour suppressor that is frequently dysregulated in many tumour tissues and lines of tumour cells. Androgen and Estrogen receptor (AR & ER) were evolving as a target to examine among hormone proteins since it appears to show a part at numerous phases of growth of breast and prostate cancers. For that kind of reason, AR and ER are becoming very relevant in recent times. Although its position remains problematic in medical care, the various finding had demonstrated a link among microRNAs 26, a group of receptors of genetic expression, and cancer (AR & ER), but there is still little evidence for the association among BC and PC miRNAs. The major goal of our study is to deliver AR and ER pathways involved in the development of microRNAs 26. Moreover, the functional and structural analysis of microRNAs 26 concerning cancer and non-cancerous cells were also discussed briefly. Additionally, the gene for post-transcriptional regulatory functions in breast and prostate cancer of different dysfunctional miRNAs 26 and their medicinal properties were also presented.
650		0	_94639 _aPHARMACEUTICS
700			_914696 _a Nilugal, Kiran Chanabasappa
773	0		_dBengluru Association of Pharmaceutical Teachers of India (APTI) _tIndian journal of pharmaceutical education and research _x0019-5464
856			_uhttps://www.ijper.org/sites/default/files/IndJPhaEdRes-55-3-738.pdf _yClick here
942			_2ddc _cAR